Discovery and Characterization of Pure RhlR Antagonists against Pseudomonas aeruginosa Infections.
SangJin NamSo-Young HamHongmok KwonHan-Shin KimSuhyun MoonJeong-Hoon LeeTaehyeong LimSang-Hyun SonHee-Deung ParkYoungjoo ByunPublished in: Journal of medicinal chemistry (2020)
Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic human pathogen that forms biofilms and produces virulence factors via quorum sensing (QS). Blocking the QS system in P. aeruginosa is an excellent strategy to reduce biofilm formation and the production of virulence factors. RhlR plays an essential role in the QS system of P. aeruginosa. We synthesized 55 analogues based on the chemical structure of 4-gingerol and evaluated their RhlR inhibitory activities using the cell-based reporter strain assay. Comprehensive structure-activity relationship studies identified the alkynyl ketone 30 as the most potent RhlR antagonist. This compound displayed selective RhlR antagonism over LasR and PqsR, strong inhibition of biofilm formation, and reduced production of virulence factors in P. aeruginosa. Furthermore, the survival rate of Tenebrio molitor larvae treated with 30 in vivo greatly improved. Therefore, compound 30, a pure RhlR antagonist, can be utilized for developing QS-modulating molecules in the control of P. aeruginosa infections.
Keyphrases
- biofilm formation
- pseudomonas aeruginosa
- candida albicans
- cystic fibrosis
- staphylococcus aureus
- structure activity relationship
- escherichia coli
- acinetobacter baumannii
- endothelial cells
- high throughput
- single cell
- stem cells
- cell therapy
- molecular docking
- crispr cas
- zika virus
- newly diagnosed
- case control
- free survival
- molecular dynamics simulations
- drosophila melanogaster